This study includes a comparative analysis of four graphene-based electrochemical sensors used for the detection of melatonin, an endogenous hormone involved in circadian rhythm regulation and associated with various neurological pathologies. The sensors were based on screen-printed electrodes (SPE) modified with graphene (G), graphene modified with gold nanoparticles (AuNPs/G), graphene oxide (GO), and reduced graphene oxide (rGO). Melatonin was extracted from commercially available pharmaceutical products, purified, and characterized using UV-Vis spectroscopy, FTIR spectrometry, and HPLC. The performance of the electrodes was evaluated via cyclic voltammetry, using potassium ferrocyanide and standard melatonin solutions to determine the kinetic characteristics, while square-wave voltammetry was employed to determine the detection and quantification limits. G/SPE showed the best performance, with a detection limit of 0.3424 μM, followed by AuNPs/G/SPE with an LOD of 1.2768 μM. GO/SPE had the poorest performance (LOD 23.1056 μM), and rGO/SPE had an LOD of 5.8503 μM. Testing of sensors on pharmaceuticals showed accurate quantification of melatonin in a complex environment. The results highlight the potential of G/SPE and AuNPs/G/SPE sensors for use in the rapid and accurate detection of melatonin in pharmaceutical and biomedical applications.
Trifan et al. (Fri,) studied this question.